Send us Feedback

GALECTIN THERAPEUTICS INC (OTC:GALT)
Analysis
SUMMARY
BULLS
BEARS
Data
STOCK CHART
QUOTE AND NEWS
Galectin (GALT) Posts Q1 Loss of 22c/Share
StreetInsider.com  May 10  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Galectin+%28GALT%29+Posts+Q1+Loss+of+22cShare/8327893.html for the full story.
Galectin (GALT) Issues Encouraging Update on anti-Galectin Drugs on Liver Cirrohsis
StreetInsider.com  Apr 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Galectin+%28GALT%29+Issues+Encouraging+Update+on+anti-Galectin+Drugs+on+Liver+Cirrohsis/8284498.html for the full story.
Galectin Therapeutics Announces Discovery Program for New Anti-Galectin Drugs in Collaboration with University of Georgia
Benzinga  Feb 19  Comment 
Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced today the establishment of a collaborative drug discovery program with Dr. Geert-Jan Boons'...
Galectin (GALT) Submites IND for New GR-MD-02 Indication
StreetInsider.com  Jan 31  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Galectin+%28GALT%29+Submites+IND+for+New+GR-MD-02+Indication/8046786.html for the full story.
Galectin Therapeutics (GALT) Receives U.S. Patent NoA on Galectin Inhibitors in Liver Disease
StreetInsider.com  Nov 26  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Galectin+Therapeutics+%28GALT%29+Receives+U.S.+Patent+NoA+on+Galectin+Inhibitors+in+Liver+Disease/7901523.html for the full story.
Galectin (GALT) Posts Q3 Loss of 19c/Share
StreetInsider.com  Nov 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Galectin+%28GALT%29+Posts+Q3+Loss+of+19cShare/7863445.html for the full story.
Galectin Therapeutics Names Shlevin COO
Benzinga  Aug 29  Comment 
Galectin Therapeutics Inc. (NASDAQ: GALT) today announced the appointment of Dr. Harold H. Shlevin as Chief Operating Officer. Dr. Shlevin succeeds, as of October 1, 2012, Maureen Foley who helped found the Company and served as its COO since its...
Galectin (GALT) Reports Q2 Loss of $0.19
StreetInsider.com  Aug 10  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Galectin+%28GALT%29+Reports+Q2+Loss+of+%240.19/7651023.html for the full story.
Unusual 11 Mid-Day Movers 07/23: (GALT) (NXY) (GEOY) Higher; (ITMN) (WSLA) (PETS) Lower
StreetInsider.com  Jul 23  Comment 
Galectin Therapeutics (Nasdaq: GALT) 65.2% HIGHER; received a notice of issuance from the U.S. Patent and Trademark Office for Patent Number 8,236,780 “Galactose-prolonged polysaccharides in a formulation for antifibrotic therapies”. The...
UPDATE: Galectin (GALT) Gets U.S. Patent for Carb-Based Galectin Inhibitor; Shares Volatile
StreetInsider.com  Jul 23  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/UPDATE%3A+Galectin+%28GALT%29+Gets+U.S.+Patent+for+Carb-Based+Galectin+Inhibitor%3B+Shares+Volatile/7595918.html for the full story.




more ▼WIKI ANALYSIS
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800.
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


You may also be interested in articles related to GALECTIN THERAPEUTICS INC (OTC:GALT):
 
Retrieved from "http://www.wikinvest.com/stock/GALECTIN_THERAPEUTICS_INC_(OTC:GALT)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki